← Back to Search

Behavioral Intervention

Digital App for Leukemia (NAVIGATE Trial)

N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Hospitalized patients (age > 18 years) with a diagnosis of AML
Ability to comprehend and speak English as the digital apps are only available in English
Must not have
Patients with a diagnosis of acute promyelocytic leukemia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 180 days
Awards & highlights

Summary

This trial is looking at how a new self-administered digital app called DREAMLAND can help improve the quality of life and mental well-being of patients with acute myeloid leukemia who are undergoing

Who is the study for?
This trial is for hospitalized adults over 18 with acute myeloid leukemia (AML), starting intensive chemotherapy that requires a long hospital stay. Participants must understand and speak English as the digital apps are in English only. Those with acute promyelocytic leukemia or unstable psychiatric conditions can't join.
What is being tested?
The study tests a new self-administered digital app called DREAMLAND, aimed at improving life quality and mental health for AML patients during their intense chemotherapy treatment in the hospital.
What are the potential side effects?
Since this trial involves a digital application rather than medication, traditional side effects are not expected; however, users may experience discomfort or stress from using the technology.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 and hospitalized with acute myeloid leukemia.
Select...
I can understand and speak English.
Select...
I am starting a strong chemotherapy that needs a long hospital stay.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with acute promyelocytic leukemia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 180 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 180 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient reported quality of life (QOL) at day 20 as measured by the Functional Assessment of Cancer Therapy-Leukemia scale
Secondary study objectives
Longitudinal patient reported quality of life (QOL) as measured by the Functional Assessment of Cancer Therapy-Leukemia scale
Participant anxiety symptoms assessed by the Hospital Anxiety and Depression Scale
Participant depression symptoms as measured by the Hospital Anxiety Depression scale
+3 more
Other study objectives
Participant experience of application's usability as measured by the Systems Usability Scale
Participant perceived ability to used adaptive coping as measured by the Measure of Current Status Part A
Participant self-efficacy level as measured by the Cancer Self-Efficacy scale

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: DREAMLANDExperimental Treatment1 Intervention
DREAMLAND is a self-administered, multicomponent mobile psychological intervention application for patients to be used during their hospitalization for intensive chemotherapy.
Group II: VITAL WELLNESSActive Control1 Intervention
VITAL WELLNESS is a self-administered, multicomponent mobile application containing information on a range of physical health topics that guide patients through education about general wellness, nutrition, exercise, and cancer prevention.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,993 Previous Clinical Trials
13,230,521 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,765 Previous Clinical Trials
8,133,311 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,002,800 Total Patients Enrolled
~133 spots leftby Apr 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top